A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

Item
http://www.wikidata.org/entity/Q33399406
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareA phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.Experimental approaches for the treatment of malignant gliomas.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy.AKT/GSK3β Signaling in Glioblastoma.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Targeted therapy in gliomas.Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.Novel N-Substituted 2-(2-(Adamantan-1-yl)-1H-Indol-3-yl)-2-Oxoacetamide Derivatives: Synthesis and Biological Evaluation.
P2860

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

Item
http://www.wikidata.org/entity/Q33399406
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A phase I study of LY317615 (e ...... h gliomas (EORTC trial 26054).
@ast
A phase I study of LY317615 (e ...... h gliomas (EORTC trial 26054).
@en
type
label
A phase I study of LY317615 (e ...... h gliomas (EORTC trial 26054).
@ast
A phase I study of LY317615 (e ...... h gliomas (EORTC trial 26054).
@en
prefLabel
A phase I study of LY317615 (e ...... h gliomas (EORTC trial 26054).
@ast
A phase I study of LY317615 (e ...... h gliomas (EORTC trial 26054).
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A phase I study of LY317615 (e ...... th gliomas (EORTC trial 26054)
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932